Skip to main content

Aggregator

In Other Journals

2 months 1 week ago
Science, Volume 391, Issue 6790, Page 1116-1117, March 2026.
Corinne Simonti, and Jesse Smith, Joana Osório, Yevgeniya Nusinovich, Corinne Simonti, Mattia Maroso, Angela Hessler, Marc S. Lavine, and Jake S. Yeston

My new apprentice

2 months 1 week ago
Science, Volume 391, Issue 6790, Page 1178-1178, March 2026.
Ariel Rosenfeld

Ravens anticipate wolf kill sites across broad scales

2 months 1 week ago
Science, Volume 391, Issue 6790, Page 1151-1154, March 2026.
Matthias-Claudio Loretto, Kristina B. Beck, Douglas W. Smith, Daniel R. Stahler, Lauren E. Walker, Martin Wikelski, Thomas Mueller, Kamran Safi, John M. Marzluff

Strong and brittle lithium dendrites

2 months 1 week ago
Science, Volume 391, Issue 6790, Page 1125-1129, March 2026.
Qing Ai, Boyu Zhang, Xing Liu, Bongki Shin, Wenhua Guo, Guanhui Gao, Lihong Zhao, Xintong Weng, Qiyi Fang, Tianshu Zhai, Doug Steinbach, Yifan Zhu, Yifeng Liu, Fan Wang, Xiaoyin Tian, Hua Guo, Youtian Zhang, Xuan Zhao, Yimo Han, Ming Tang, Yan Yao, Ting…

The emergence of neuropsychiatric symptoms in preclinical Alzheimer's disease: An emotion regulation perspective

2 months 1 week ago
Preclinical Alzheimer's disease (AD) is associated with distressing neuropsychiatric symptoms (NPSs) that may accelerate progression toward dementia. Existing approaches probe the symptom-level domain-general or domain-specific neural correlates of NPSs. However, the field lacks process-oriented models of symptom emergence for targeted treatment. We propose one pathway for symptom emergence involving the disruption of emotion regulation (ER) systems by early AD pathology. AD pathology in the...
Adam Turnbull

Harmine and its derivatives: A promising multi-target therapeutic avenue for Alzheimer's disease

2 months 1 week ago
Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by β-amyloid (Aβ) deposition, tau hyperphosphorylation, neuroinflammation, and cholinergic dysfunction. Currently, no disease-modifying drugs are available, and existing symptomatic treatments offer limited efficacy while posing safety concerns, highlighting the urgent need for multi‑target therapeutic strategies. The natural β‑carboline alkaloid harmine has attracted considerable attention due to its favorable...
Xue Shen